ARTICLE

OVERVIEW OF PEPTIC ULCER ALONG WITH ITS CONVENTIONAL AND IMPROVEMENT THERAPIES A STUDY OF GLYCOPYRROLATE AND MANAGEMENT OF PEPTIC ULCER

  1. HOME
  2. ARTICLE

05 Pages : 39-52

http://dx.doi.org/10.31703/gpsr.2023(VIII-III).05      10.31703/gpsr.2023(VIII-III).05      Published : Sep 2023

Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer

Abstract

    Peptic ulcer disease remains a prevalent gastrointestinal disorder globally, posing significant challenges in its management. This comprehensive review provides an overview of peptic ulcer pathology, conventional treatment modalities, and recent advancements in therapeutic approaches. Traditional treatments, among them histamine receptor antagonists, proton pump inhibitors, and antibiotic regimens, have shown efficacy in ulcer healing and symptom alleviation. However, emerging evidence suggests limitations such as drug resistance and adverse effects. In light of these challenges, this article delves into the potential of Glycopyrrolate, a muscarinic receptor antagonist, as a novel therapeutic agent for peptic ulcer management. However, still there may be aggravation of peptic ulcer leading to severe conditions like perforated gastric ulcer, and gastric bleeding where surgery is only beneficial.

    eptic Ulcer , Glycopyrrolate , Ulcer Management , Helicobacter Pylori , Proton Pump Inhibitors , Histamine H2-receptor Antagonists ,Antacids, Mucosal Protective Agents

    (1) Kainat Hameed
    Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
    (2) Amna Shahid
    Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
    (3) Abiha Zainab
    Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
    (4) Ahsan Zafar
    Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Fulltext PDF

References

  • Anesini, C., & Pérez, C. (1993). Screening of plants used in Argentine folk medicine for antimicrobial activity. Journal of Ethnopharmacology, 39(2), 119–128. https://doi.org/10.1016/0378-8741(93)90027-3

  • Armstrong, C. P., & Blower, A. L. (1987). Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 28(5):527-32. https://doi.org/10.1136/gut.28.5.527.  
  • Bechara, R., & Kanagasabai, V. V. (2018). A52 endoscopic closure of perforated peptic ulcer in a patient who was a challenging candidate for surgical management. Journal of the Canadian Association of Gastroenterology, 1(suppl_2), 84. https://doi.org/10.1093/jcag/gwy009.052
  • Bharati, A. C., Sahu, A. N. (2012). Ethnobotany, phytochemistry and pharmacology of Biophytum sensitivum DC. Pharmacogn Rev. 6(11):68-73. https://doi.org/10.4103/0973-7847.95893. 
  • Birol, S. (2019). Management of peptic ulcer perforations; Comparison of open and laparoscopic procedures. Laparoscopic Endoscopic Surgical Science (Online). https://doi.org/10.14744/less.2019.83097
  • Bitsch, V., & Kristensen, M. (1966). Determination of Peptic Activity and Acid in the Gastric Juice of Patients with Peptic Disease Before and After Administration of Glycopyrrolate. Acta Medica Scandinavica, 180(4), 385–394. https://doi.org/10.1111/j.0954-6820.1966.tb02849.x
  • Boyanova, L., Stancheva, I., Spassova, Z., Katzarov, N., Mitov, I., & Koumanova, R. (2000). Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. Journal of Medical Microbiology/Journal of Medical Microbiology, 49(5), 415–418. https://doi.org/10.1099/0022-1317-49-5-415
  • Chabicovsky, M., Winkler, S., Soeberdt, M., Kilić, A., Masur, C., & Abels, C. (2019). Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicology and Applied Pharmacology, 370, 154–169. https://doi.org/10.1016/j.taap.2019.03.016 
  • Chi, F., & Zhou, S. (2022). Recurrent bleeding from a duodenal ulcer halted by laparoscopic oversewing under endoscopic guidance. JCPSP, 32(08), S121–S123. https://doi.org/10.29271/jcpsp.2022.supp2.s121
  • Chiu, P. W. (2019). Endoscopic Management of peptic ulcer bleeding: Recent advances. Clinical Endoscopy, 52(5), 416–418. https://doi.org/10.5946/ce.2018.182
  • Cho, H., Choi, M., Cho, D., Yeo, C., Jeong, H., Shon, J., Lee, J., Shin, J., Cho, M., Kim, D. Y., & Shin, J. (2012). Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics and pharmacodynamics of a new proton pump inhibitor, ilaprazole. Journal of Clinical Pharmacology, 52(7), 976–984. https://doi.org/10.1177/0091270011408611
  • Dadfar, A., & Edna, T. (2020). Epidemiology of perforating peptic ulcer: A population-based retrospective study over 40 years. World Journal of Gastroenterology, 26(35), 5302–5313. https://doi.org/10.3748/wjg.v26.i35.5302
  • Ezekian, B., & Perez, A. (2016). Management of bleeding peptic ulcer disease. In Springer eBooks (51–61). https://doi.org/10.1007/978-3-319-40646-6_5
  • Gómez-Ferrer, F., Balique, J. G., Azagra, S., Castelo, H. B., Castro-Sousa, F., Espalieuh, P., Rodero, D. R., & Estour, E. (1996). Laparoscopic surgery for duodenal ulcer: First results of a multicentre study applying a personal procedure. British Journal of Surgery, 83(4), 547–550. https://doi.org/10.1002/bjs.1800830437
  • Gupta, A., Shetty, S., Mutalik, S., H, R. C., Nandakumar, K., Mathew, E. M., Jha, A., Mishra, B., Rajpurohit, S., Ravi, G., Saha, M., & Moorkoth, S. (2023). Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation. Heliyon, 9(10), e20406. https://doi.org/10.1016/j.heliyon.2023.e20406
  • Hamedeyazdan, Y. J. a. S. (2014). Floating Drug Delivery Systems for Eradication of Helicobacter pylori in Treatment of Peptic Ulcer Disease. In InTech eBooks. https://doi.org/10.5772/57353
  • Hermansson, M., Von Holstein, C. S., & Zilling, T. (1997). Peptic Ulcer Perforation before and after the Introduction of H2-Receptor Blockers and Proton Pump Inhibitors. Scandinavian Journal of Gastroenterology, 32(6), 523–529. https://doi.org/10.3109/00365529709025093
  • Hou, C., Yin, F., Wang, S., Zhao, A., Li, Y., & Yi-Pin, L. (2022). Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents. Infection and Drug Resistance, 15, 1561–1571. https://doi.org/10.2147/idr.s357473
  • Huang, J., Sridhar, S., & Hunt, R. H. (2002). Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet, 359(9300), 14–22. https://doi.org/10.1016/s0140-6736(02)07273-2
  • Jang, J. Y. (2016). Recent Developments in the Endoscopic Treatment of Patients with Peptic Ulcer Bleeding. Clinical Endoscopy, 49(5), 417–420. https://doi.org/10.5946/ce.2016.135
  • Kamada, T., Satoh, K., Itoh, T., Ito, M., Iwamoto, J., Okimoto, T., Kanno, T., Sugimoto, M., Chiba, T., Nomura, S., Mieda, M., Hiraishi, H., Yoshino, J., Takagi, A., Watanabe, S., & Koike, K. (2021). Evidence-based clinical practice guidelines for peptic ulcer disease 2020. Journal of Gastroenterology, 56(4), 303–322. https://doi.org/10.1007/s00535-021-01769-0
  • Kostov, K. (2019). Role of laparoscopic surgery for the management of perforated peptic ulcer. Outcomes of 37 cases. Journal of IMAB, 25(4), 2812–2816. https://doi.org/10.5272/jimab.2019254.2812
  • Lanas, Á., & Chan, F. K. (2017). Peptic ulcer disease. Lancet, 390(10094), 613–624. https://doi.org/10.1016/s0140-6736(16)32404-7
  • Latif, A. a. A., Mahmoud, M., & Al-Mezaien, O. (2022). Laparoscopic repair of perforated duodenal ulcer: a comparison with the open surgical technique. Al-Azhar International Medical Journal /Al-Azhar International Medical Journal, 3(1), 76–80. https://doi.org/10.21608/aimj.2022.103320.1632
  • Malfertheiner, P., Chan, F. K., & McColl, K. E. (2009). Peptic ulcer disease. Lancet, 374(9699), 1449–1461. https://doi.org/10.1016/s0140-6736(09)60938-7
  • Manco, G., Caramaschi, S., Rolando, G., Malagoli, M., Zanelli, G., Bonetti, L. R., & Rossi, A. (2020). Primary laparoscopic approach to repair perforated peptic ulcer. A retrospective cohort study. Minerva Chirurgica, 75(6). https://doi.org/10.23736/s0026-4733.20.08287-5
  • Moêller, H. (1962). Physiological effects and clinical evaluation of glycopyrrolate in peptic ulcer disease. Annals of the New York Academy of Sciences, 99(1), 158–162. https://doi.org/10.1111/j.1749-6632.1962.tb56665.x
  • Narayanan, M., Reddy, K. M., & Marsicano, E. (2018). Peptic Ulcer Disease and Helicobacter pylori infection. Mo Med. 115(3):219-224. 
  • Penttilä, J., Helminen, A., Luomala, K., & Scheinin, H. (2001). Pharmacokinetic–pharmacodynamic model for the anticholinergic effect of glycopyrrolate. European Journal of Clinical Pharmacology, 57(2), 153–158. https://doi.org/10.1007/s002280100288
  • Ranjan, K. N., Shreechandan, P., Priyadarshini, P., & Sampad, S. S. (2017). Herbal drugs in treatment of peptic ulcer. J Bio Innov, 6(3), 499-508. 
  • Samie, A., Tanih, N. F., & Ndip, R. N. (2014). Helicobacter pylori Infection — Challenges of Antimicrobial Chemotherapy and Emergence of Alternative Treatments. In InTech eBooks. https://doi.org/10.5772/57462
  • Scally, B., Emberson, J., Spata, E., Reith, C., Davies, K. J., Halls, H., Holland, L., Wilson, K., Bhala, N., Hawkey, C. J., Hochberg, M. C., Hunt, R. H., Laine, L., Lanas, F., Patrono, C., & Baigent, C. (2018). Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. ˜the œLancet. Gastroenterology & Hepatology, 3(4), 231–241. https://doi.org/10.1016/s2468-1253(18)30037-2 
  • Shavakhi, A., Tabesh, E., Yaghoutkar, A., Hashemi, H., Tabesh, F., Khodadoostan, M., Minakari, M., Shavakhi, S., & Gholamrezaei, A. (2013). The Effects of Multistrain Probiotic Compound on Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo‐Controlled Triple‐Blind Study. Helicobacter, 18(4), 280–284. https://doi.org/10.1111/hel.12047
  • Silva, M. I. G., & De Sousa, F. C. F. (2011). Gastric ulcer etiology. In InTech eBooks. https://doi.org/10.5772/20796
  • Silva, M. I. G., & De Sousa, F. C. F. (2011b). Gastric ulcer etiology. In InTech eBooks. https://doi.org/10.5772/20796
  • Sivam, G. (2001). Protection against Helicobacter pylori and Other Bacterial Infections by Garlic. ˜the œJournal of Nutrition/˜the œJournal of Nutrition, 131(3), 1106S-1108S. https://doi.org/10.1093/jn/131.3.1106s
  • Stewart, D. J., & Ackroyd, R. (2008). Peptic ulcers and their complications. Surgery, 26(11), 452–457. https://doi.org/10.1016/j.mpsur.2008.09.007
  • Van Nguyen, H., Baek, N., & Lee, B. (2017). Enhanced gastric stability of esomeprazole by molecular interaction and modulation of microenvironmental pH with alkalizers in solid dispersion. International Journal of Pharmaceutics, 523(1), 189–202. https://doi.org/10.1016/j.ijpharm.2017.03.047
  • Zittel, T. T., Jehle, E. C., & Becker, H. D. (2000). Surgical management of peptic ulcer disease today - indication, technique, and outcome. Langenbeck’s Archives of Surgery, 385(2), 84–96. https://doi.org/10.1007/s004230050250
  • Zittel, T. T., Jehle, E. C., & Becker, H. D. (2000b). Surgical management of peptic ulcer disease today - an indication, technique and outcome. Langenbeck’s Archives of Surgery, 385(2), 84–96. https://doi.org/10.1007/s004230050250

Cite this article

APA

    APA : Hameed, K., Shahid, A., & Zainab, A. (2023). Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer. Global Pharmaceutical Sciences Review, VIII(III), 39-52. https://doi.org/10.31703/gpsr.2023(VIII-III).05

CHICAGO

    CHICAGO : Hameed, Kainat, Amna Shahid, and Abiha Zainab. 2023. "Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer." Global Pharmaceutical Sciences Review, VIII (III): 39-52 doi: 10.31703/gpsr.2023(VIII-III).05

HARVARD

    HARVARD : HAMEED, K., SHAHID, A. & ZAINAB, A. 2023. Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer. Global Pharmaceutical Sciences Review, VIII, 39-52.

MHRA

    MHRA : Hameed, Kainat, Amna Shahid, and Abiha Zainab. 2023. "Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer." Global Pharmaceutical Sciences Review, VIII: 39-52

MLA

    MLA : Hameed, Kainat, Amna Shahid, and Abiha Zainab. "Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer." Global Pharmaceutical Sciences Review, VIII.III (2023): 39-52 Print.

OXFORD

    OXFORD : Hameed, Kainat, Shahid, Amna, and Zainab, Abiha (2023), "Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer", Global Pharmaceutical Sciences Review, VIII (III), 39-52

TURABIAN

    TURABIAN : Hameed, Kainat, Amna Shahid, and Abiha Zainab. "Overview of Peptic Ulcer along with its Conventional and Improvement Therapies: A Study of Glycopyrrolate and Management of Peptic Ulcer." Global Pharmaceutical Sciences Review VIII, no. III (2023): 39-52. https://doi.org/10.31703/gpsr.2023(VIII-III).05